Advertisement

Topics

Reddy US Therapeutics, Inc Company Profile

19:42 EDT 21st October 2018 | BioPortfolio

Reddy US Therapeutics, Inc., part of Dr. Reddy's Discovery Research, was established in November 1999. Our company is located in the wooded suburbs of Atlanta. We currently occupy over 25000 sq. ft. of a state-of-the-art laboratory facility that is designed and equipped for molecular biological, biochemical and chemical research.Our company has been a subsidiary of Dr. Reddy's Laboratories Limited, Hyderabad, India since 2002 and was established in order to expand the drug discovery efforts of our parent company. Our location in the U.S. offers us unique access to talent and technologies that complement the expertise and experience of Dr. Reddy's Laboratories Limited. We have assembled a highly talented group of scientists who are creatively attacking the underlying mechanisms of the unmet medical needs in inflammation, lipid metabolism and cardiovascular disease. Our research is focused on identification of novel therapeutics that target the regulation of gene expression and protein function.

Location

3065 Northwoods Circle
Norcross
Georgia
30071-1542
United States of America

Contact

Phone: 770-446-9500
Fax: 770-446-1950
Email: jobs@reddyus.com


News Articles [907 Associated News Articles listed on BioPortfolio]

Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech

Dr. Reddy’s Laboratories has signed a distribution agreement with UCB to supply the latter’s epilepsy drug Briviact in India. As...Read More... The post Deals this week: Dr. Reddy’s Labo...

Dr. Reddy’s Laboratories sells antibiotic manufacturing site in Bristol, Tennessee

Under the terms of the agreement, Dr. Reddy’s sold all the issued and outstanding membership interests in Dr. Reddy’s Laboratories Tennessee, LLC and certain related assets. Dr. Reddy’s The pos...

Dr. Reddy's Launches First Generic Suboxone Film; Indivior May Seek Injunction

Launch comes immediately after FDA approval of Dr. Reddy's and Mylan ANDAs while Indivior appeals district court ruling of non-infringement;...   

FDA approves Dr. Reddy's Aggrenox generic capsules

Dr. Reddy's Laboratories' Aspirin and Extended-Release Dipyridamole capsules was granted approval by the FDA.  -More- 

BRIEF—Dr Reddy’s files NDA for its migraine candidate

India’s Dr Reddy’s Laboratories has announced the filing of New Drug Application (NDA) for its migraine…

US court issues a restraint order against Dr Reddy’s new drug

Indian pharmaceutical company Dr Reddy’s Laboratories has announced that the US District Court in New Jersey has issued a temporary restraining...Read More... The post US court issues a restraint o...

Dr Reddy’s prepares for Duvvada re-inspection following Form 483

Dr Reddyâs expects to have addressed all GMP violations at its Duvvada drug formulation plant and Srikakulam API facility within the next six weeks, says CEO.

Dr. Reddy's Laboratories Regains Worldwide Rights To DFA-02

NEW DELHI (dpa-AFX) - Dr. Reddy's Laboratories Ltd. (RDY), along with its subsidiaries, announced the termination of the license granted to Armis Biopharma, Inc. for its investigational antibacter...

PubMed Articles [450 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development: Preclinical Research.

Clinical Trials [208 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

The objective of this study was to compare the rate and extent of absorption of Dr. Reddy's Zonisamide 100 mg Capsule to that of Zonegran® 100 mg Capsule after a single, one-capsule dose ...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [1279 Associated Companies listed on BioPortfolio]

Reddy US Therapeutics, Inc

Reddy US Therapeutics, Inc., part of Dr. Reddy's Discovery Research, was established in November 1999. Our company is located in the wooded suburbs of Atlanta. We currently occupy over 25000 sq. ft. o...

Dr. Reddy's Laboratories Inc

Since its inception in 1984, Dr. Reddy's has chosen to walk the path of discovery and innovation in health sciences. Ours has been a quest to sustain and improve the quality of life, and we have had n...

Dr. Reddy's Laboratories Ltd.

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Thro...

Dr. Reddy’s Laboratories

Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company. We fulfill our purpose of providing affordable and innovative medicine...

Dr. Reddy’s Laboratories Ltd.

Unaudited Consolidated Income Statement

More Information about "Reddy US Therapeutics, Inc" on BioPortfolio

We have published hundreds of Reddy US Therapeutics, Inc news stories on BioPortfolio along with dozens of Reddy US Therapeutics, Inc Clinical Trials and PubMed Articles about Reddy US Therapeutics, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Reddy US Therapeutics, Inc Companies in our database. You can also find out about relevant Reddy US Therapeutics, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record